FRIEDBERG, Germany and BAYERN, Germany, May 04, 2020 (GLOBE NEWSWIRE) -- Advanced BioInformatics GmbH, a medical technology company developing solutions that improve long-term outcomes for people with ...

The FDA has started testing the precisionFDA platform it developed with DNAnexus. The closed beta test phase is the precursor to a more widespread rollout of the system, which the CEO of DNAnexus has ...

A free open-access webinar will introduce the Cancer Genome Interpreter (CGI), an advanced bioinformatics tool to interpret mutations in cancer genomes developed by IRB Barcelona and co-created with ...

Immunotherapy is being hailed as the future of cancer treatment. Harnessing the body’s own immune system to attack and kill cancer cells, immunotherapy is a burgeoning field of medicine that offers a ...

Research collaboration: Queensland Facility for Advanced Bioinformatics (QFAB) is a research collaboration whose article contributions are accrued to its participating partner institutions. Represents ...

Exiqon A/S has announced the extension of the miRCURY™ LNA microRNA PCR product line with the launch of a novel bioinformatics software for the design of custom qPCR assays for microRNA quantification ...

Austin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Bioinformatics Market Size Analysis: “According to SNS Insider, The Bioinformatics Market Size was valued at USD 11.45 billion in 2023 and is projected to ...

Identifying biomarkers that predict which patient populations are most likely to respond to a particular treatment can increase the chances of a new investigational drug ultimately entering the market ...

VEDBAEK, Denmark, Oct. 12, 2010 (GLOBE NEWSWIRE) -- Exiqon A/S (Copenhagen:EXQ), a leading supplier of high-value gene expression analysis products, today announced the extension of the miRCURY LNA ...